维普中文期刊产品整合服务
55篇 您的检索式:作者名="Bulent M"
    题名 作者 年代 出处 被引量
1帕博利珠单抗治疗伴脑转移NSCLC患者的一项非随机、开放Ⅱ期试验的长期随访结果和生物标志物分析显示文摘背景与目的我们开展了一项帕博利珠单抗用于伴未治疗脑转移的非小细胞肺癌(non-small cell lung cancer,NSCLC)或黑色素瘤患者的疗效和安全性的II期试验,旨在评估程序性死亡受体1(programmed cell death 1,PD-1)抑制剂在中枢神经系统(central nervous system,CNS)中的疗效。中期结果已发表,现报道对NSCLC队列的更新分析结果。方法这是一项开放性、单中心、II期试验。纳入标准:年龄≥18岁,诊断为晚期NSCLC并伴有≥1个5 mm-20 mm脑转移病灶,既往从未治疗或之前放疗后进展,无神经系统症状,不需要激素治疗且美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)<2分。患者每2周接受一次帕博利珠单抗(10 mg/kg)治疗。队列1为程序性死亡配体1(programmed cell death ligand 1,PD-L1)≥1%的患者,队列2为PD-L1<1%或未评估的患者。主要终点是脑转移患者缓解比例。所有经治患者均纳入疗效与安全性终点的分析。该研究已结束入组,并于Clinicaltrials.gov登记注册,注册号为NCT02085070。结果2014年3月31日-2018年5月21日,共42例患者接受治疗。中位随访时间为8.3个月(IQR:4.5个月-26.2个月)。队列1的37例患者中11例有脑转移缓解[29.7%(95%CI:15.9%-47.0%)]。队列2未观察到缓解。治疗相关的3级-4级不良事件(adverse events,AEs)包括2例肺炎、1例全身症状、1例结肠炎、1例肾上腺皮质功能不全、1例高血糖症和1例低钾血症。6例(14%)患者发生了治疗相关的严重不良事件,包括肺炎、急性肾损伤、低钾血症和肾上腺皮质功能不全。没有观察到治疗相关死亡病例。结论帕博利珠单抗治疗PD-L1≥1%的NSCLC伴脑转移患者有效,且对所有纳入的未经治疗的脑转移患者安全。需要进一步探索免疫治疗用于NSCLC合并CNS转移。Sarah B GOLDBERG Kurt A SCHALPER Scott N GETTINGER Amit MAHAJAN Roy S HERBST Anne C CHANG Rogerio LILENBAUM Frederick H WILSON Sacit Bulent OMAY James B YU Lucia JILAVEANU Thuy TRAN Kira PAVLIK Elin ROWEN Heather GERRSH Annette KOMLO Richa GUPTA Hailey WYATT Matthew RIBEIRO Yuval KLUGER Geyu ZHOU Wei WEI Veronica L CHANG Harriet M KLUGER 董晓荣(翻译/校对) 2021中国肺癌杂志2021,24,9:34
2Does physical therapy and rehabilitation improve outcomes for diabetic foot ulcers?显示文摘One of the most common and serious complications of diabetes mellitus is ulceration of the foot. Among persons with diabetes, 12%-25% will present to a healthcare institution for a foot disorder during their lifespan. Despite currently available medical and surgical treatments, these are still the most common diabetes-related cause of hospitalization and of lower extremity amputations. Thus, many adjunctive and complementary treatments have been developed in an attempt to improve outcomes. We herein review the available literature on the effectiveness of several treatments, including superficial and deep heaters, electro-therapy procedures, prophylactic methods, exercise and shoe modifications, on diabetic foot wounds. Overall, although physical therapy modalities seem to be useful in the treatment of diabetic foot wounds, further randomized clinical studies are required.Yasemin Turan Bulent M Ertugrul Benjamin A Lipsky Kevser Bayraktar 2015World Journal of Experimental Medicine2015,5,2:7
3Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors显示文摘AIM:To evaluate systemic treatment choices in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors(PNETs)and provide consensus treatment recommendations.METHODS:Systemic treatment options for pancreatic neuroendocrine tumors have expanded in recent years to include somatostatin analogs,angiogenesis inhibitors,inhibitors of mammalian target of rapamycinand cytotoxic agents.At this time,there is little data to guide treatment selection and sequence.We therefore assembled a panel of expert physicians to evaluate systemic treatment choices and provide consensus treatment recommendations.Treatment appropriateness ratings were collected using the RAND/UCLA modified Delphi process.After studying the literature,a multidisciplinary panel of 10 physicians assessed the appropriateness of various medical treatment scenarios on a 1-9 scale.Ratings were done both before and after an extended discussion of the evidence.Quantitative measurements of agreement were made and consensus statements developed from the second round ratings.RESULTS:Specialties represented were medical and surgical oncology,interventional radiology,and gastroenterology.Panelists had practiced for a mean of15.5 years(range:6-33).Among 202 rated scenarios,disagreement decreased from 13.2%(26 scenarios)before the face-to-face discussion of evidence to 1%(2)after.In the final ratings,46.5%(94 scenarios)were rated inappropriate,21.8%(44)were uncertain,and30.7%(62)were appropriate.Consensus statements from the scenarios included:(1)it is appropriate to use somatostatin analogs as first line therapy in patients with hormonally functional tumors and may be appropriate in patients who are asymptomatic;(2)it is appropriate to use everolimus,sunitinib,or cytotoxic chemotherapy therapy as first line therapy in patients with symptomatic or progressive tumors;and(3)beyond first line,these same agents can be used.In patients with uncontrolled secretory symptoms,octreotide LAR doses can be titrated up to 60 mg every4 wk or up to 40 mg every 3 or 4 wk.CONCLUSION:Using the Delphi process allowed physician experts to systematically obtain a consensus on the appropriateness of a variety of medical therapies in patients with PNETs.Jonathan R Strosberg George A Fisher Al B Benson Lowell B Anthony Bulent Arslan John F Gibbs Edward Greeno Renuka V Iyer Michelle K Kim William J Maples Philip A Philip Edward M Wolin Dasha Cherepanov Michael S Broder 2015World Journal of Gastroenterology2015,21,8:2
4Ovarian wedge resection by minilaparatomy in infertile patients with polycystic ovarian syndrome: a new technique 显示文摘Yildirim M Noyan V Bulent Tiras M Yildiz A Guner H 2003Eur J Obstet Gynecol Reprod Biol2003,107,1:1
5Multi-scale modeling of localized heating caused by ion bombardment 显示文摘MICHAEL T M BULENT H S LIN S 2011Nuclear Instrument and Methods in Physics Research B2011,272,:1
6The changes in ovarianhormone levels and ovarian artery blood flow rate after tubaI steril-ization显示文摘 Noyan V Ozdemir H 2000Eur J Obstet Gynecol Reprod Biol2000,99,2:1
7Urinary IL-18 :a marker of con- trast-induced nephropathy following percutaneous coronary inter- vention?显示文摘Bulent Gul CB Gullulu M Oral B 2008Clin Bioehem2008,41,78:1
8Immobilizationofcandidarugosalipaseontospacer-armattachedpoly(GMA-HE-MA-EGDMA)microspheres显示文摘GULAYB BULENT K ARICA M Y 0,,:1
9Ovarian wedge resection by minilaparatomy in infertile patients with polycystic ovarian syndrome: a new technique 显示文摘Mulazim Yildirim Volkan Noyan M Bulent Tiras 2003Eur J Obstet Gynecol Reprod Biol2003,107,1:1
10Evaluation of Circulation Disorder in Coronary Slow Flow by Fundus Fluorescein Angiography显示文摘?ahbender Ko? Bulent Ozin Cihan Alt?n Rana Altan Yayc?o?lu Alp Ayd?nalp Haldun Müderrisoglu 2013The American Journal of Cardiology2013,,11:1
11Progressive failure analysis of pin-loaded carbon- epoxy woven composite plates显示文摘BULENT M 2002Composites Science and Technology2002,62,9:1
12Comparison of plate-screw fixation and intramedullary fixation with inflatable nails in the treatment of acute humeral shaft fractures显示文摘Bulent D Onder M Bulent A T 2007Acta Orthop Traumatol Turc2007,41,1:1
13Low cost techniques for the preparation of Cu (In,Ga)(Se,S)2 absorber tayers显示文摘Bulent M Basol 2000Thin Solid Films2000,,:1
14The use of methanol as fuel at high compression ratio in a single cylinder gasoline engine显示文摘BahattinCelik M Bulent Ozdalyan Faruk Alkan 2010Fuel2010,90,4:1
15Revisiting firm characteristics,strategy,and export performance relationship:a survey of the literature and an investigation of New Zealand small manufacturing firms显示文摘DAVID L D BULENT M MYERS C P 2000Industrial Marketing Management2000,29,:1
16Ovarian wedge resection by minilaparatomy in infertile patients with polycystic ovarian syndrome:a new technique显示文摘Yildifim M Noyan V Bulent TM 2003Fur J Obstet Gynecol Reprod Bid2003,107,1:1
17Landfill leachate management in Istaabul: applications and alternatives 显示文摘BARIS C BULENT M BULENT I 2005Chemo- sphere2005,59,:1
18Top Management Team Diversity and Innovativeness:The Moderating Role of Interfunctional Co- ordination 显示文摘Seigyoung A Bulent M 2005Industrial Marketing Management2005,34,1:1
19Comparison of determinate andindeterminate lines of sesame for agronomic traits显示文摘Bulent Uzun Ilhan Cagirgan M 2006Field CropsResearch2006,96,1:1
20The Influence of Top Management Team Functional Diversity on Strategic Orientations: The Moderating Role of Environmental Turbulence and Interfunctional Coordination 显示文摘SEIJYOUNG A BULENT M 2005International Journal of Research in Marketing2005,22,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费